Michèle Rousseau1,2, Justine Horne1,2, Frédéric Guénard1, Juan de Toro-Martín1, Véronique Garneau1,2, Valérie Guay1, Michèle Kearney1, Geneviève Pilon1,3, Denis Roy1, Patrick Couture1, Charles Couillard1,2, André Marette1,3, Marie-Claude Vohl4,5. 1. Centre Nutrition, santé et société (NUTRISS)-Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec, QC, G1V 0A6, Canada. 2. School of Nutrition, Université Laval, Québec, QC, G1V 0A6, Canada. 3. Québec Heart and Lung Institute (IUCPQ) Research Center, 2725 chemin Sainte-Foy, Québec, QC, G1V 4G5, Canada. 4. Centre Nutrition, santé et société (NUTRISS)-Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec, QC, G1V 0A6, Canada. marie-claude.vohl@fsaa.ulaval.ca. 5. School of Nutrition, Université Laval, Québec, QC, G1V 0A6, Canada. marie-claude.vohl@fsaa.ulaval.ca.
Abstract
BACKGROUND: Blueberries contain high levels of polyphenolic compounds with high in vitro antioxidant capacities. Their consumption has been associated with improved vascular and metabolic health. PURPOSE: The objective was to examine the effects of blueberry supplement consumption on metabolic syndrome (MetS) parameters and potential underlying mechanisms of action. METHODS: A randomized double-blind placebo-controlled intervention trial was conducted in adults at risk of developing MetS. Participants consumed 50 g daily of either a freeze-dried highbush blueberry powder (BBP) or a placebo powder for 8 weeks (n = 49). MetS phenotypes were assessed at weeks 0, 4 and 8. Fasting blood gene expression profiles and plasma metabolomic profiles were examined at baseline and week 8 to assess metabolic changes occurring in response to the BBP. A per-protocol analysis was used. RESULTS: A significant treatment effect was observed for plasma triglyceride levels that was no longer significant after further adjustments for age, sex, BMI and baseline values. In addition, the treatment*time interactions were non-significant therefore suggesting that compared with the placebo, BBP had no statistically significant effect on body weight, blood pressure, fasting plasma lipid, insulin and glucose levels, insulin resistance (or sensitivity) orglycated hemoglobin concentrations. There were significant changes in the expression of 49 genes and in the abundance of 35 metabolites following BBP consumption. Differentially regulated genes were clustered in immune-related pathways. CONCLUSION: An 8-week BBP intervention did not significantly improve traditional markers of cardiometabolic health in adults at risk of developing MetS. However, changes in gene expression and metabolite abundance suggest that clinically significant cardiometabolic changes could take longer than 8 weeks to present and/or could result from whole blueberry consumption or a higher dosage. BBP may also have an effect on factors such as immunity even within a shorter 8-week timeframe. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, NCT03266055 , 2017.
RCT Entities:
BACKGROUND: Blueberries contain high levels of polyphenolic compounds with high in vitro antioxidant capacities. Their consumption has been associated with improved vascular and metabolic health. PURPOSE: The objective was to examine the effects of blueberry supplement consumption on metabolic syndrome (MetS) parameters and potential underlying mechanisms of action. METHODS: A randomized double-blind placebo-controlled intervention trial was conducted in adults at risk of developing MetS. Participants consumed 50 g daily of either a freeze-dried highbush blueberry powder (BBP) or a placebo powder for 8 weeks (n = 49). MetS phenotypes were assessed at weeks 0, 4 and 8. Fasting blood gene expression profiles and plasma metabolomic profiles were examined at baseline and week 8 to assess metabolic changes occurring in response to the BBP. A per-protocol analysis was used. RESULTS: A significant treatment effect was observed for plasma triglyceride levels that was no longer significant after further adjustments for age, sex, BMI and baseline values. In addition, the treatment*time interactions were non-significant therefore suggesting that compared with the placebo, BBP had no statistically significant effect on body weight, blood pressure, fasting plasma lipid, insulin and glucose levels, insulin resistance (or sensitivity) or glycated hemoglobin concentrations. There were significant changes in the expression of 49 genes and in the abundance of 35 metabolites following BBP consumption. Differentially regulated genes were clustered in immune-related pathways. CONCLUSION: An 8-week BBP intervention did not significantly improve traditional markers of cardiometabolic health in adults at risk of developing MetS. However, changes in gene expression and metabolite abundance suggest that clinically significant cardiometabolic changes could take longer than 8 weeks to present and/or could result from whole blueberry consumption or a higher dosage. BBP may also have an effect on factors such as immunity even within a shorter 8-week timeframe. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov, NCT03266055 , 2017.
Authors: Louis C Martineau; Audrey Couture; Danielle Spoor; Ali Benhaddou-Andaloussi; Cory Harris; Bouchra Meddah; Charles Leduc; Andrew Burt; Tri Vuong; Phuong Mai Le; Marc Prentki; Steffany A Bennett; John T Arnason; Pierre S Haddad Journal: Phytomedicine Date: 2006-09-18 Impact factor: 5.340
Authors: Xianli Wu; Gary R Beecher; Joanne M Holden; David B Haytowitz; Susan E Gebhardt; Ronald L Prior Journal: J Agric Food Chem Date: 2006-05-31 Impact factor: 5.279
Authors: Jason DeFuria; Grace Bennett; Katherine J Strissel; James W Perfield; Paul E Milbury; Andrew S Greenberg; Martin S Obin Journal: J Nutr Date: 2009-06-10 Impact factor: 4.798
Authors: Kelly L Wolfe; Xinmei Kang; Xiangjiu He; Mei Dong; Qingyuan Zhang; Rui Hai Liu Journal: J Agric Food Chem Date: 2008-08-30 Impact factor: 5.279
Authors: Gloria I Solano-Aguilar; Sukla Lakshman; Jonathan Shao; Celine Chen; Ethiopia Beshah; Harry D Dawson; Bryan Vinyard; Steven G Schroeder; Saebyeol Jang; Aleksey Molokin; Joseph F Urban Journal: Nutrients Date: 2021-12-02 Impact factor: 5.717